Maarten Rijpert

Alkmaar, NH, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Safety and effectiveness of the early-onset sepsis calculator to reduce antibiotic exposure in at-risk newborns: a cluster-randomised controlled trial.

Safety and effectiveness of the early-onset sepsis calculator to reduce antibiotic exposure in at-risk newborns: a cluster-randomised controlled trial.

Journal: EClinicalMedicine

Published: June 13, 2025

Short-Term Outcomes of Implementing Less Invasive Surfactant Therapy in Infants Born Less than 30 Weeks: A Retrospective Trend Analysis.

Short-Term Outcomes of Implementing Less Invasive Surfactant Therapy in Infants Born Less than 30 Weeks: A Retrospective Trend Analysis.

Journal: The Journal of pediatrics

Published: March 19, 2025

Impact of Implementing Nasal High Flow Therapy on Body Growth in Preterm Infants.

Impact of Implementing Nasal High Flow Therapy on Body Growth in Preterm Infants.

Journal: Neonatology

Published: January 23, 2025

Incidence of Antibiotic Exposure for Suspected and Proven Neonatal Early-Onset Sepsis between 2019 and 2021: A Retrospective, Multicentre Study.

Incidence of Antibiotic Exposure for Suspected and Proven Neonatal Early-Onset Sepsis between 2019 and 2021: A Retrospective, Multicentre Study.

Journal: Antibiotics (Basel, Switzerland)

Published: May 13, 2024

Association between bronchopulmonary dysplasia severity and its risk factors and long-term outcomes in three definitions: a historical cohort study.

Association between bronchopulmonary dysplasia severity and its risk factors and long-term outcomes in three definitions: a historical cohort study.

Journal: Archives of disease in childhood. Fetal and neonatal edition

Published: January 30, 2024

Risk Factors for Neurodevelopmental Impairment at 2- and 5-Years Corrected Age in Preterm Infants with Established Bronchopulmonary Dysplasia.

Risk Factors for Neurodevelopmental Impairment at 2- and 5-Years Corrected Age in Preterm Infants with Established Bronchopulmonary Dysplasia.

Journal: Neonatology

Published: May 19, 2023

Differences in systemic and mucosal SARS-CoV-2 antibody prevalence in a prospective cohort of Dutch children.

Differences in systemic and mucosal SARS-CoV-2 antibody prevalence in a prospective cohort of Dutch children.

Journal: Frontiers in immunology

Published: June 23, 2022

Comparison of New Bronchopulmonary Dysplasia Definitions on Long-Term Outcomes in Preterm Infants.

Comparison of New Bronchopulmonary Dysplasia Definitions on Long-Term Outcomes in Preterm Infants.

Journal: The Journal of pediatrics

Published: March 25, 2022

Saliva SARS-CoV-2 Antibody Prevalence in Children.

Saliva SARS-CoV-2 Antibody Prevalence in Children.

Journal: Microbiology spectrum

Published: September 15, 2021

Severity of Bronchopulmonary Dysplasia and Neurodevelopmental Outcome at 2 and 5 Years Corrected Age.

Severity of Bronchopulmonary Dysplasia and Neurodevelopmental Outcome at 2 and 5 Years Corrected Age.

Journal: The Journal of pediatrics

Published: September 02, 2021

Current treatment practice of functional abdominal pain disorders in children: A multicenter survey.

Current treatment practice of functional abdominal pain disorders in children: A multicenter survey.

Journal: Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology

Published: July 19, 2021

Multicentre study found that adherence to national antibiotic recommendations for neonatal early-onset sepsis was low.

Multicentre study found that adherence to national antibiotic recommendations for neonatal early-onset sepsis was low.

Journal: Acta paediatrica (Oslo, Norway : 1992)

Published: April 12, 2020

Showing 1-12 of 14

Last Updated: 09/26/2026